Overview: What Is DeepScribe?
DeepScribe is a San Francisco-based AI medical scribe founded in 2017, focused on specialty practices, oncology departments, and ambulatory clinics. While Abridge dominates large enterprise health systems and Freed dominates the SMB segment, DeepScribe occupies the high end of the specialty-clinic and mid-market hospital segment with the highest measured KLAS quality scores in the entire ambient AI category.
DeepScribe positions itself not as a "scribe" but as an "Ambient Operating System" — a layer that captures the patient encounter, generates the note, codes it, pre-charts the next visit, and surfaces clinical insights in real time. The pitch is that ambient AI should not just transcribe; it should compress administrative work across the entire patient encounter lifecycle.
The KLAS Score That Matters
DeepScribe holds a 98.8/100 KLAS Spotlight Score with A+ ratings across all six measured categories: product quality, implementation, customer service, executive involvement, money's worth, and likelihood to recommend. KLAS scores are based on direct interviews with clinician customers, not vendor self-reporting, which makes them the most credible third-party measure in healthcare IT.
DeepScribe also placed Top 5 in three of the four "Quadruple Aim" categories at the 2025 KLAS Emerging Solutions Top 20 — meaning customers report measurable improvements in patient experience, clinician experience, clinical outcomes, and cost reduction. Among AI scribes, only Abridge has comparable KLAS recognition, and DeepScribe's specialty-tuned models give it an edge in oncology, cardiology, and other high-complexity specialties.
Pricing
| Plan | Price | Details |
|---|---|---|
| Standard | $350–$500/month per provider (estimated) | EHR integration may add ~$100/month per provider, Custom templates and specialty fields at premium tier, Pricing varies by practice size and specialty |
DeepScribe is not publicly priced. Industry estimates put it at $350-$500/month per provider for the standard product, with EHR integration adding approximately $100/month/provider and custom specialty templates at premium tiers. This positions DeepScribe roughly comparable to Suki ($299-$399/month) and modestly cheaper than Nuance DAX ($600+/month), but dramatically more expensive than Freed ($39-$119/month).
For solo and small practices, the cost differential makes Freed the more sensible starting point. For specialty groups and hospitals where documentation quality directly affects coding revenue and clinical outcomes, DeepScribe's quality premium can be cost-justified.
Key Features
- Ambient AI capture with specialty-tuned models
- AI-powered medical coding (E/M, HCC, ICD-10)
- AI pre-charting from prior visit data
- Bi-directional EHR write-back
- DeepScribe Assist — real-time clinical insights
- Context-aware documentation
- Customizable note templates
- Largest clinical dataset in healthcare (proprietary)
Specialty-tuned models are DeepScribe's primary differentiator. Generic ambient AI scribes struggle with the dense, specialty-specific terminology of oncology, cardiology, and surgical sub-specialties. DeepScribe trains separate models per specialty, which materially improves transcription accuracy for terms like "trastuzumab deruxtecan," "TAVR," or "diffuse large B-cell lymphoma."
AI-powered medical coding is another genuine differentiator. The system suggests E/M codes, HCC codes for risk adjustment, and ICD-10 codes based on the captured encounter. For specialty practices where coding accuracy directly drives revenue, this feature alone can justify the price.
Strengths and Weaknesses
Strengths
- ✓ Highest KLAS Spotlight Score in ambient AI (98.8/100)
- ✓ A+ ratings across all six measured categories
- ✓ Specialty-tuned AI models (oncology, cardiology, etc.)
- ✓ AI medical coding suggestions (E/M, HCC, ICD-10)
- ✓ Bi-directional EHR write-back
Weaknesses
- ✗ Pricing opaque and reportedly higher than newer competitors
- ✗ Smaller health system footprint compared to Nuance or Abridge
- ✗ EHR integration adds extra cost
- ✗ Less well-known brand outside specialty medicine
- ✗ Limited public information on total deployment count
DeepScribe vs Abridge vs Freed
Abridge dominates large enterprise health systems on Epic. DeepScribe wins on specialty practices and oncology where its tuned models have a real accuracy edge. Freed wins on small practices and price-sensitive solo clinicians where the $39-$119/month price point is the only viable option. Read our full Freed vs DeepScribe comparison.
Verdict
DeepScribe is the right AI scribe for specialty practices, oncology departments, and mid-market health systems where documentation quality directly affects clinical and revenue outcomes. The 98.8/100 KLAS score is the most credible third-party validation in the entire ambient AI category. We recommend DeepScribe for specialty groups; we recommend Freed for solo practices and Abridge for Epic-based enterprise health systems.